Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer.

Gundula Rendl; Lukas Rettenbacher; Gregor Schweighofer-Zwink; Lukas Hehenwarter; Christian Pirich

doi:10.1055/a-1111-8927

Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer.

Gundula Rendl (First author), Lukas Rettenbacher (Co-author), Gregor Schweighofer-Zwink (Co-author), Lukas Hehenwarter (Co-author), Christian Pirich (Last author)

Department of Nuclear Medicine and Endocrinology

Research output: Contribution to journal › Original Article (Journal) › peer-review

3 Citations (Web of Science)

Original language	English
Pages (from-to)	158-167
Journal	HORMONE AND METABOLIC RESEARCH
Volume	52
Issue number	3
DOIs	https://doi.org/10.1055/a-1111-8927
Publication status	Published - 2020

Keywords

POSITRON-EMISSION-TOMOGRAPHY
WHOLE-BODY SCAN
NA+/I-SYMPORTER
SERUM THYROGLOBULIN
CARCINOMA
RECURRENCE
EXPRESSION
METASTASES
ACCURACY

Access to Document

10.1055/a-1111-8927

Cite this

Rendl, G., Rettenbacher, L., Schweighofer-Zwink, G., Hehenwarter, L., & Pirich, C. (2020). Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer. HORMONE AND METABOLIC RESEARCH , 52(3), 158-167. https://doi.org/10.1055/a-1111-8927

Rendl, Gundula ; Rettenbacher, Lukas ; Schweighofer-Zwink, Gregor et al. / Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer. In: HORMONE AND METABOLIC RESEARCH 2020 ; Vol. 52, No. 3. pp. 158-167.

@article{82fcdf136ae7473b8d6ebd3730a073ab,

title = "Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer.",

keywords = "POSITRON-EMISSION-TOMOGRAPHY, WHOLE-BODY SCAN, NA+/I-SYMPORTER, SERUM THYROGLOBULIN, CARCINOMA, RECURRENCE, EXPRESSION, METASTASES, ACCURACY",

author = "Gundula Rendl and Lukas Rettenbacher and Gregor Schweighofer-Zwink and Lukas Hehenwarter and Christian Pirich",

note = "all: Department of Nuclear Medicine and Endocrinology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria ",

year = "2020",

doi = "10.1055/a-1111-8927",

language = "English",

volume = "52",

pages = "158--167",

journal = "HORMONE AND METABOLIC RESEARCH ",

issn = "0018-5043",

publisher = "Thieme Medical Publishers, US ",

number = "3",

}

Rendl, G, Rettenbacher, L, Schweighofer-Zwink, G , Hehenwarter, L & Pirich, C 2020, 'Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer.', HORMONE AND METABOLIC RESEARCH , vol. 52, no. 3, pp. 158-167. https://doi.org/10.1055/a-1111-8927

Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer. / Rendl, Gundula (First author); Rettenbacher, Lukas (Co-author); Schweighofer-Zwink, Gregor (Co-author) et al.
In: HORMONE AND METABOLIC RESEARCH , Vol. 52, No. 3, 2020, p. 158-167.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer.

AU - Rendl, Gundula

AU - Rettenbacher, Lukas

AU - Schweighofer-Zwink, Gregor

AU - Hehenwarter, Lukas

AU - Pirich, Christian

N1 - all: Department of Nuclear Medicine and Endocrinology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria

PY - 2020

Y1 - 2020

KW - POSITRON-EMISSION-TOMOGRAPHY

KW - WHOLE-BODY SCAN

KW - NA+/I-SYMPORTER

KW - SERUM THYROGLOBULIN

KW - CARCINOMA

KW - RECURRENCE

KW - EXPRESSION

KW - METASTASES

KW - ACCURACY

U2 - 10.1055/a-1111-8927

DO - 10.1055/a-1111-8927

M3 - Original Article (Journal)

C2 - 32215887

SN - 0018-5043

VL - 52

SP - 158

EP - 167

JO - HORMONE AND METABOLIC RESEARCH

JF - HORMONE AND METABOLIC RESEARCH

IS - 3

ER -

Rendl G, Rettenbacher L, Schweighofer-Zwink G , Hehenwarter L , Pirich C. Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer. HORMONE AND METABOLIC RESEARCH . 2020;52(3):158-167. doi: 10.1055/a-1111-8927